1. Project
  2. RespiriTB
  3. Organisations

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Full project page

Organisations map overview


Powered by Chris Decubber BV